NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eugene M. JohnstonCFO2025-12-153,333$1.17
$3.88kSell
Eugene M. JohnstonCFO2025-12-095,000$1.20
$5.98kSell
Eugene M. JohnstonCFO2025-12-0510,000$1.13
$11.28kSell
Alex P. HamiltonDirector2025-11-19125,000$1.22
$152.88kSell

1 of 1

MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan Arango5.82%1,000,000$546.00kInsider
Jacob D. Cohen3.52%605,000$330.33kInsider
Geode Capital Management LLC1.13%194,482$106.19kInstitution
Amanda Elizabeth Hammer1.02%175,000$95.55kInsider
Ikarian Capital LLC0.80%138,146$75.43kInstitution
Kenny Myers0.80%136,667$74.62kInsider
Lorraine Pamela Dalessio0.80%136,667$74.62kInsider
Vanguard Capital Management LLC0.72%123,041$67.18kInstitution
Eugene M. Johnston0.70%120,000$65.52kInsider
Jane Street Group LLC0.42%72,746$39.72kInstitution

1 of 3

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX4.81%13.03%Net Selling
BFRG2.87%13.32%
ACON3.91%54.47%Net Buying
HCTI0.19%99.81%
MNDR1.86%98.14%

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 4.81% institutional shareholders, 13.03% Mangoceuticals insiders, and 82.16% retail investors. Jonathan Arango is the largest individual Mangoceuticals shareholder, owning 1.00M shares representing 5.82% of the company. Jonathan Arango's Mangoceuticals shares are currently valued at $533.00k.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.